Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: A study with quantitative magnetic resonance imaging

Molecular Psychiatry

Volumn 2, Issue 6, 1997, Pages 505-507

  Schroder J ^a,e   Pantel, J ^a   Ida, N ^b   Essig, M ^c   Hartmann, T ^b   Knopp, M V ^c   Schad, L R ^c   Sandbrink, R ^b   Sauer, H ^d   Masters, C L ^d   Beyreuther, K ^b  

^a Section of Geriatric Psychiatry   (Germany)

^b INF 282   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Dept of Psychiatry ^*  (Australia)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Cerebral atrophy; Magnetic resonance imaging; Medication effects; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TEMPORAL LOBE; BRAIN SIZE; CARBOXY TERMINAL SEQUENCE; CEREBROSPINAL FLUID; PROTEIN VARIANT;

EID: 0030831053     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000313     Document Type: Article

References (16)

1. Ida N, Hartmann T, Pantel J, Schröder J, Zerfass R, Förstl H, Sandbrink R, Masters CL, Beyreuther K. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 1996; 37: 22908-22914.
2. Blessed G, Tomlinson BE, Roth M. The associations between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.
3. Cummings BJ, Cotman CW. Image analysis of amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 1995; 346: 1524-1528.
4. Nagy ZS, Jobst KA, Esiri MM, Morris JH, King EMF, MacDonald R, Barnetson L, Smith AD. Hippocampal pathology reflects memory deficits and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. Dementia 1996; 7: 76-81.
5. Pantel J, Schröder J, Schad LR, Friedlinger M, Knopp MV, Schmitt R, Geissler M, Blüml S, Essig M, Sauer H. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol Med 1997; 27: 221-229.
6. Pantel J, Schröder J, Essig M, Popp D, Dech H, Knopp MV, Schad LR, Eysenbach K, Backenstraß M, Friedlinger M. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J Affect Dis 1907; 42: 69-83.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984; 34: 939-965.
8. American Psychiatric Association. Diagnostische Kriterien und Differentialdiagnosen des diagnostichen und statistichen Manuals psychischer Störungen DSM-III-R. Beltz-Verlag: Weinheim Basel, 1989.
9. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R. Reduction of beta-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995; 38: 643-648.
10. Southwick PC, Yamagata SK, Echols CL Jr, Higson GJ, Neynaber SA, Parson RE, Munroe WA, Assessment of amyloid beta protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. J Neurochem 1996; 66: 259-265.
11. van Goo WA, Kuiper MA, Walstra GJ, Woltors EC, Bolhuis PA. Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995; 37: 277-279.
12. Nitsch RM, Rebeck GW, Deng M, Richardson UI, Tennis M, Schenk AD, Vigo-Pelfrey C, Leiberburg I, Wurtman RJ, Hyman BT. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype. Ann Neurol 1995; 37: 512-518.
13. Nakamura T, Shoji M, Harigaya Y, Watanabe M, Hosoda K, Cheung TT, Shaffer LM, Golde TE, Younkin LH, Younkin SG. Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Ann Neurol 1994; 36: 903-911.
14. Sandbrink R, Hartmann T, Masters CL, Beyreuther K. Genes contributing to Alzheimer's disease. Mol Psychiatry 1996; 1: 27-40.
15. Folstein MF, Folstein SE, Hugh PR. 'Minimental-state': a practical method for grading the cognitive state of patients for the clinician. J Psych Res 1975; 12: 189-198.
16. Schad LR, Blüml S, Hawighorst H, Wenz F, Lorenz WJ. Radiosurgical treatment planning of brain metastases based on a fast, three dimensional MR imaging technique. Mag Res Imag 1994; 12: 811.